supp.fit

Milk Thistle: study protocols

31 study groups say how much Milk Thistle participants took a day. These are the doses the studies gave. They are not a recommendation.

Milk Thistle: what the research found →

Dose per serving from products

2,656 products in our catalogue print how much Milk Thistle a serving holds.

Most common: 100 mg to 250 mg, 43% of 2,656 products.

Dose per servingProducts
10 mg or less
61
10 mg to 25 mg
113
25 mg to 50 mg
239
50 mg to 100 mg
412
100 mg to 250 mg
1,134
250 mg to 500 mg
453
500 mg to 1 g
181
over 1 g
63

Dose per serving from research

31 study groups in 29 studies say how much Milk Thistle participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 42% of 31 study groups.

Daily doseStudy groups
100 mg or less
1
100 mg to 250 mg
8
250 mg to 500 mg
13
500 mg to 1 g
7
1 g to 2.5 g
2

Commonly used together

11 of 31 study groups took Milk Thistle with something else, but nothing that 3 or more different studies gave.

31 study groups

Study
Promising efficacy of oral nano-silymarin formulation on prevention of vancomycin-induced nephrotoxicity: a randomized, triple-blinded, placebo-controlled clinical trial
2026 · nano-silymarin · Patients receiving vancomycin for infection and at risk of vancomycin-induced nephrotoxicity
140 mg2 weeks—
Evaluation of the effect of Silybum marianum extract on menopausal symptoms: A randomized, double-blind placebo-controlled trial
2020 · S. marianum extract · Women with hot flashes and menopausal symptoms; age not reported
400 mg12 weeks40
Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
2016 · silymarin group · Patients with head and neck cancer receiving radiotherapy
420 mg6 weeks—
Silymarin in combination with hair follicle transplantation as a potential treatment for refractory vitiligo: A double-blind randomized controlled trial
2024 · Silymarin plus hair follicle transplantation · Adults aged 18–59 with stable, non-segmental refractory vitiligo
140 mg90 days10
The role of a fixed Berberis aristata/Silybum marianum combination in the treatment of type 1 diabetes mellitus
2016 · B. aristata/S. marianum (Berberol) · Patients with type 1 diabetes mellitus
210 mg26 weeks—
The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial
2006 · silymarin group · People with type II diabetes
600 mg120 days25
Use of selenium-silymarin mix reduces lower urinary tract symptoms and prostate specific antigen in men
2013 · selenium-silymarin group · Men with lower urinary tract symptoms and benign prostatic hyperplasia, with PSA ≤2.5 ng/ml
570 mg26 weeks26
The safety and efficacy of a silymarin and selenium combination in men after radical prostatectomy - a six month placebo-controlled double-blind clinical trial
2010 · SM-Se group · Men 2–3 months after radical prostatectomy
570 mg26 weeks19
A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis
2009 · silymarin group · Patients aged 13 years or older with symptomatic acute hepatitis and ALT greater than 2.5 times the upper limit of normal
420 mg4 weeks55
Immunomodulatory effects of silymarin in patients with β-thalassemia major
2013 · combined therapy group · Patients with β-thalassemia major
420 mg12 weeks25
A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)
2010 · Milk thistle (MT) group · Children aged 1–21 years with acute lymphoblastic leukemia in the maintenance phase of chemotherapy and grade 2 or greater hepatic toxicity
240 mg4 weeks24
Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial
2015 · silymarin treatment group · Patients aged 25–50 with type 2 diabetes mellitus on stable medication
420 mg45 days20
Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: A Triple-blinded randomized controlled clinical trial
2018 · silymarin group · Men and women aged 25–50 with type 2 diabetes mellitus on stable medication
420 mg45 days20
Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: A randomized, triple blind, placebo-controlled clinical trial
2022 · silymarin group · Patients with non-metastatic breast cancer receiving the AC-T chemotherapy regimen
420 mg30 days15
Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial
2009 · Silymarin group · Patients with beta-thalassemia major
420 mg90 days—
Adjunctive silymarin supplementation and its effects on disease severity, oxidative stress, and inflammation in patients with Alzheimer's disease
2024 · case group · Patients with Alzheimer's disease confirmed by DSM-5 criteria and brain imaging; age and sex not stated
450 mg90 days—
Evaluation of oral silymarin formulation efficacy in prevention of doxorubicin induced hepatotoxicity in patients with non-metastatic breast cancer
2025 · silymarin group · Patients with non-metastatic breast cancer receiving doxorubicin-containing chemotherapy
420 mg9 weeks—
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C
2011 · 280 mg silymarin · Adults with noncirrhotic nonalcoholic fatty liver disease or hepatitis C
840 mg7 days—
The activity of a herbal medicinal product of Phyllanthus niruri and Silybum marianum powdered extracts (Heptex®) in patients with apparent risk factors for nonalcoholic steatohepatitis: a phase II, multicentered, randomized, double-blind, placebo-controlled clinical trial
2025 · high-dose Heptex® · Adults aged 18–65, both sexes, with elevated liver enzymes, steatosis and F1/F2 fibrosis scores; apparent risk factors for NASH
300 mg36 weeks44
The activity of a herbal medicinal product of Phyllanthus niruri and Silybum marianum powdered extracts (Heptex®) in patients with apparent risk factors for nonalcoholic steatohepatitis: a phase II, multicentered, randomized, double-blind, placebo-controlled clinical trial
2025 · low-dose Heptex® · Adults aged 18–65, both sexes, with elevated liver enzymes, steatosis and F1/F2 fibrosis scores; apparent risk factors for NASH
300 mg36 weeks41
Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans
2006 · Milk thistle · Healthy young adults; 8 women and 8 men, mean age 26 years
900 mg2 weeks16
The iron-chelating potential of silybin in patients with hereditary haemochromatosis
2010 · Silybin · Adults with HFE-related hereditary haemochromatosis, 9 male and 1 female, with grade 4 siderosis and fibrosis or cirrhosis
140 mg1 day10
Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients
2013 · Berberis aristata/Silybum marianum extract · Dyslipidemic, euglycemic patients
210 mg26 weeks—
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses
2015 · B. aristata/S. marianum · Adults with dyslipidemia who had experienced adverse events while taking high-dose statins and tolerated a half-dose statin
210 mg26 weeks—
Superior silybin bioavailability of silybin-phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers
2019 · Conventional SM tablets · Healthy men and women aged 18–44 years
70 mg1 day23
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C
2011 · 560 mg silymarin · Adults with noncirrhotic nonalcoholic fatty liver disease or hepatitis C
1.68 g7 days—
Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlled Trial
2017 · Berberol K · Adults aged 18 or older, either sex, with low cardiovascular risk, hypercholesterolemia, overweight, and normal blood pressure
105 mg90 days73
A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis
2017 · silymarin group · Adults with biopsy-proven nonalcoholic steatohepatitis (NASH) and a NAFLD activity score of 4 or more
2.1 g48 weeks49
Silymarin, Olibanum, and Nettle, A Mixed Herbal Formulation in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial
2017 · Herbal Formulation · Adults aged 40–60 with type II diabetes mellitus
600 mg90 days30
Phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study
2013 · active dietary intervention (ADI) · Patients with previous sporadic colonic adenomas scheduled for surveillance colonoscopy
350 mg60 days—
A Randomized Controlled Trial of a Herbal Compound for Improving Metabolic Parameters in Diabetic Patients with Uncontrolled Dyslipidemia
2019 · intervention group · Adults with type 2 diabetes and dyslipidemia despite statin therapy; age and sex not specified
1 g12 weeks25